Communications about COVID-19

The latest updates on the COVID-19 pandemic from AIFA are available below

Comunicazioni su COVID-19

11/11/2022

Direct communication with healthcare professionals on Spikevax bivalent booster vaccines

04/11/2022

Monitoring of antivirals for COVID-19: new report published

03/11/2022

Thirteenth AIFA Report on the surveillance of anti-COVID-19 vaccines

03/11/2022

Monitoring of monoclonal antibodies for COVID-19: weekly report published

28/10/2022

Estensione automatica della scadenza dei certificati GMP durante l’emergenza COVID-19 (aggiornamento del 28/10/2022)

21/10/2022

Monitoring of antivirals for COVID-19: new report published

20/10/2022

Monitoring of monoclonal antibodies for COVID-19: weekly report published

20/10/2022

EMA recommends approval of Comirnaty and Spikevax COVID-19 vaccines for children from 6 months of age

20/10/2022

EMA recommends approval of second adapted Spikevax vaccine

10/10/2022

Monitoring of antivirals for COVID-19: new report published

06/10/2022

Monitoring of monoclonal antibodies for COVID-19: weekly report published

23/09/2022

Monitoring of antivirals for COVID-19: new report published

22/09/2022

Monitoring of monoclonal antibodies for COVID-19: weekly report published

21/09/2022

EMA recommends standard marketing authorisations for Comirnaty and Spikevax COVID-19 vaccines

14/09/2022

AIFA authorises Comirnaty Original bivalent vaccine for Sars-Cov-2 Omicron BA.4-5 variants

13/09/2022

Adapted vaccine targeting BA.4 and BA.5 Omicron variants and original SARS-CoV-2 recommended for approval

09/09/2022

Monitoring of antivirals for COVID-19: new report published

09/09/2022

Monitoring of monoclonal antibodies for COVID-19: weekly report published

07/09/2022

COVID-19: recommendations on use of adapted vaccines

05/09/2022

AIFA approves booster dose with Comirnaty and Spikevax bivalent vaccines

All news

Page 3 of 25
— 20 Items per Page
Showing 41 - 60 of 493 results.